The progression of chronic glomerulopathy and graft rejection is affected by a number of proinflammatory cytokines, whose role in the pathogenesis of damage is poorly understood. The aim of this dissertation was to identify reliable risk markers of renal dysfunction progression and thereby contribute to a more effective patient treatment. Human native kidney biopsies with histologically confirmed diagnosis of glomerulopathy or kidney graft biopsies were analysed. Intrarenal gene expressions were measured by RT-qPCR. Single nucleotide polymorphisms were detected by methods based on PCR-RFLP. Immunohistochemical staining was used to identify and quantify the mononuclear cell infiltration. Gene expression of TGF-β1, HGF, BMP7, MCP-1, RANTES an...
Glomerulosclerosis is a general term describing the process of scarring of the glomeruli, the functi...
Focal segmental glomerulosclerosis (FSGS) accounts for about 40% of all nephrotic syndrome cases in ...
Acute rejection (AR) is a dominant risk factor for developing chronic allograft nephropathy (CAN) af...
The progression of chronic glomerulopathy and graft rejection is affected by a number of proinflamma...
Acute rejection and chronic transplant nephropathy are the main complications after kidney transplan...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
Background. Delayed graft function (DGF) remains an important problem after kidney transplantation a...
graft function determined by the increase of serum cre-atinine frequently reflects the already devel...
AIMS: Grafts have been shown to be sites where the alloimmune response develops in a direct interact...
In 2010, 307 Swedish patients received a new kidney through transplantation, and the first of April ...
AIMS: Grafts have been shown to be sites where the alloimmune response develops in a direct interact...
AIMS: Grafts have been shown to be sites where the alloimmune response develops in a direct interact...
Renal allografts inevitably develop progressive morphological and functional deterioration. Naesens ...
Both antibody mediated (AMR) and T-cell mediated (TCMR) rejections either acute or chronic represent...
Glomerulosclerosis is a general term describing the process of scarring of the glomeruli, the functi...
Glomerulosclerosis is a general term describing the process of scarring of the glomeruli, the functi...
Focal segmental glomerulosclerosis (FSGS) accounts for about 40% of all nephrotic syndrome cases in ...
Acute rejection (AR) is a dominant risk factor for developing chronic allograft nephropathy (CAN) af...
The progression of chronic glomerulopathy and graft rejection is affected by a number of proinflamma...
Acute rejection and chronic transplant nephropathy are the main complications after kidney transplan...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
Background. Delayed graft function (DGF) remains an important problem after kidney transplantation a...
graft function determined by the increase of serum cre-atinine frequently reflects the already devel...
AIMS: Grafts have been shown to be sites where the alloimmune response develops in a direct interact...
In 2010, 307 Swedish patients received a new kidney through transplantation, and the first of April ...
AIMS: Grafts have been shown to be sites where the alloimmune response develops in a direct interact...
AIMS: Grafts have been shown to be sites where the alloimmune response develops in a direct interact...
Renal allografts inevitably develop progressive morphological and functional deterioration. Naesens ...
Both antibody mediated (AMR) and T-cell mediated (TCMR) rejections either acute or chronic represent...
Glomerulosclerosis is a general term describing the process of scarring of the glomeruli, the functi...
Glomerulosclerosis is a general term describing the process of scarring of the glomeruli, the functi...
Focal segmental glomerulosclerosis (FSGS) accounts for about 40% of all nephrotic syndrome cases in ...
Acute rejection (AR) is a dominant risk factor for developing chronic allograft nephropathy (CAN) af...